1 active not recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Active not recruiting 1 |
Follow Pleural Diseases: new trials by email Literature Review of Pleural Diseases trials Research Report on Pleural Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase Ⅲ Clinical Study of Combined Cisplatin Versus Placebo Combined With Intracavitary Cisplatin Injection in the Treatment of Malignant Pleural Effusions ENDOSTAR，cisplatin, Placebo , cisplatin - Malignant Pleural Effusion | Phase 3 | Active not recruiting | Jiangsu Simcere Pharmaceutical Co., Ltd. | 290 | 2021-07-28 | 2026-01-02 |
Pleural Effusion, Malignant (1)
Neoplasms (1) · Neoplasms by Site (1) · Pleural Effusion (1) · Pleural Neoplasms (1) · Respiratory Tract Diseases (1) · Respiratory Tract Neoplasms (1) · Thoracic Neoplasms (1)
Cisplatin (1)
Jiangsu Simcere Pharmaceutical Co., Ltd. (1)
China (1)
Jin Li, Doctor (1) · Shukui Qin, Doctor (1)